COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection
出版年份 2021 全文链接
标题
COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection
作者
关键词
-
出版物
Pharmaceuticals
Volume 14, Issue 1, Pages 71
出版商
MDPI AG
发表日期
2021-01-20
DOI
10.3390/ph14010071
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- COVID-19, ACE2, and the cardiovascular consequences
- (2020) Andrew M. South et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
- (2020) Yixuan J. Hou et al. CELL
- What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy
- (2020) Andy Goren et al. Dermatologic Therapy
- Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”
- (2020) Carlos Gustavo Wambier et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Excess mortality in men and women in Massachusetts during the COVID-19 pandemic
- (2020) Nancy Krieger et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
- (2020) Andrew M. South et al. Nature Reviews Nephrology
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- (2020) Andy Goren et al. Journal of Cosmetic Dermatology
- Racial Variations in COVID‐19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti‐Androgens a Potential Treatment for COVID‐19?
- (2020) John McCoy et al. Journal of Cosmetic Dermatology
- Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
- (2020) Jian-Min Jin et al. Frontiers in Public Health
- Mineralocorticoid Receptors
- (2020) Achim Lother CIRCULATION RESEARCH
- The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer
- (2020) Veronica Mollica et al. Future Oncology
- SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications
- (2020) Sonja Groß et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
- (2020) Leonidas Palaiodimos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
- (2020) Andrew Clark et al. Lancet Global Health
- COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
- (2020) Kacper Lechowicz et al. Journal of Clinical Medicine
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- (2020) Flavio A. Cadegiani et al. Frontiers in Medicine
- A novel treatment for skin repair using a combination of spironolactone and vitamin D3
- (2020) Dauren Biyashev et al. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
- Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)
- (2020) Flavio A. Cadegiani et al. MEDICAL HYPOTHESES
- Cytokine profile and disease severity in patients with COVID-19
- (2020) Ali Ghazavi et al. CYTOKINE
- Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats
- (2019) Xingxing Chen et al. LIFE SCIENCES
- Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
- (2019) Ayala Gold et al. ONCOGENE
- The renin‐angiotensin‐aldosterone system and its suppression
- (2019) Marisa K. Ames et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Flaviviridae Viruses and Oxidative Stress: Implications for Viral Pathogenesis
- (2019) Zhenzhen Zhang et al. Oxidative Medicine and Cellular Longevity
- Impact of spironolactone on markers of myocardial oxidative status, inflammation and remodeling in hyperthyroid rats.
- (2019) Fadia A Mayyas et al. Current Molecular Pharmacology
- Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
- (2019) Adam K. McDiarmid et al. Journal of the American Heart Association
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2017) Clyde W. Yancy et al. JOURNAL OF CARDIAC FAILURE
- Implications of oxidative stress on viral pathogenesis
- (2016) Fernanda Caetano Camini et al. ARCHIVES OF VIROLOGY
- Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku
- (2016) Piotr Ponikowski et al. Kardiologia Polska
- Spirolactone provides protection from renal fibrosis by inhibiting the endothelial–mesenchymal transition in isoprenaline-induced heart failure in rats
- (2016) Hao Zhou et al. Drug Design Development and Therapy
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome
- (2014) Vincenzo Marzolla et al. STEROIDS
- Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease
- (2013) Jianhua He et al. Clinical and Experimental Nephrology
- Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models
- (2013) Gissela B Lieber et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
- Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element
- (2013) Liesbeth Clinckemalie et al. MOLECULAR ENDOCRINOLOGY
- Spironolactone Attenuates Bleomycin-Induced Pulmonary Injury Partially via Modulating Mononuclear Phagocyte Phenotype Switching in Circulating and Alveolar Compartments
- (2013) Wen-Jie Ji et al. PLoS One
- Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice
- (2012) F. Zannad et al. EUROPEAN HEART JOURNAL
- Methylene Blue Protects Liver Oxidative Capacity after Gut Ischaemia–Reperfusion in the Rat
- (2012) O. Collange et al. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity
- (2009) Andrés A. Herrada et al. JOURNAL OF IMMUNOLOGY
- Androgen receptor and androgen-dependent gene expression in lung
- (2009) Laura Mikkonen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction
- (2006) Søren Ulrik Salling Sønder et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now